Dr. Sanjay Gupta

MARCH 6, 2022

Today’s video is on the subject of heart failure. Heart failure is a chronic clinical syndrome characterised by the inability of the heart to pump out enough blood to meet the body’s requirements. Anything that affects the heart in a bad way may in its severest form lead to heart failure.

Heart Failure 40

Heart Failure Quality of Life ACE Inhibitor Exercise 40

Open Heart

FEBRUARY 17, 2024

Objective To evaluate stress, depression and quality of life among community-dwelling patients with heart failure (HF) and evaluate their effect on perceived medication adherence in a socioeconomically challenged setting. were on ACE inhibitors/angiotensin receptor blockers and 54.9% The mean age was 61.3±17.36

Heart Failure 40

Heart Failure Quality of Life ACE Inhibitor COVID-19 40

Heart BMJ

MARCH 12, 2024

Introduction Takotsubo syndrome (TTS) is an acute heart failure syndrome, featured by transient left ventricular systolic dysfunction. Recurrences of TTS are not infrequent and there is no standard preventive therapy.

ACE Inhibitor 52

ACE Inhibitor Heart Failure Outcomes 52

Circulation

NOVEMBER 11, 2024

Cardiac MRI did not show significant ischemic findings.The patient received medical therapy consisting of antiplatelet agents, high dose statin, beta blocker and ACE inhibitor, as well as diuretics. In this case presentation, it is likely that his heart failure was caused by the significant left to right shunt due to the fistula.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft ACE Inhibitor Coronary Angiogram Aneurysm 40

The British Journal of Cardiology

JULY 17, 2024

These trials added weight to the evidence that supported the use of both angiotensin-converting enzyme inhibitors (ACEi) or ARBs in diabetic kidney disease and chronic kidney disease (CKD), particularly in patients with proteinuria.

Kidney Disease 40

Kidney Disease Outcomes Diabetes Heart Failure 40

DAIC

MARCH 26, 2025

Food and Drug Administration (FDA) accepted its supplemental new drug application (sNDA) and granted Priority Review designation for KERENDIA(finerenone) for the treatment of adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF).

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

Dr. Sanjay Gupta

DECEMBER 19, 2022

This is a problem that becomes more troublesome several months or years after the acute event and patients may present with breathlessness, leg swelling and all the signs of heart failure but when you look at the heart it looks like it is pumping ok so you can be misled into thinking that there is no problem with the heart.

Pericarditis 40

Pericarditis Heart Attack Heart attacks Chest Pain 40

MIBHS

OCTOBER 31, 2024

Dilation: The chambers of the heart expand, making the walls thinner. Both forms of enlargement may compromise the heart’s ability to pump blood efficiently, leading to further complications like heart failure. What Causes an Enlarged Heart? Beta-blockers , which slow the heart rate and reduce blood pressure.

Blood Pressure 52

Blood Pressure Blood Clot Heart Valves Heart Rhythm 52

Dr. Sanjay Gupta

MAY 23, 2022

Today’s vlog is on the subject of heart failure and in particular on a special type of pacemaker which can make a significant improvement to the quality of life and length of life in patients with heart failure. What is heart failure? You can download this script as a Hindi translation here.

Heart Failure 40

Heart Failure Pacemaker Quality of Life ACE Inhibitor 40

JAMA Cardiology

AUGUST 6, 2024

This secondary analysis of the Valsartan in Acute Myocardial Infarction (VALIANT) and Prospective ARNi vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI (PARADISE-MI) randomized clinical trials investigates the changes over time in sudden death rate after myocardial infarction and the characteristics of people (..)

Myocardial Infarction 87

Myocardial Infarction ACE Inhibitor Heart Failure 87

Open Heart

NOVEMBER 8, 2023

Background Currently, there is no head-to-head comparison of novel pharmacological treatments for heart failure with reduced ejection fraction (HFrEF). Methods Randomised controlled trials (RCTs) were identified from Medline, Scopus up to June 2021.

Heart Failure 52

Heart Failure ACE Inhibitor Outcomes Pharmacology 52

DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. All secondary endpoints related specifically to heart failure outcomes were significantly reduced among patients who received empagliflozin.

Heart Attack 98

Heart Attack Heart attacks Heart Failure Outpatient 98

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

Heart Attack 81

Heart Attack Heart attacks Heart Failure Outcomes 81

Circulation

NOVEMBER 11, 2024

Background:Safe dosing in children with heart failure requires consideration of clinically relevant covariates. Conclusion:The newly detected covariate Ross score provides the scientific basis for considering the severity of heart failure at the initial dose.

Heart Failure 40

Heart Failure Innovation ACE Inhibitor Congenital Heart Disease 40

European Journal of Heart Failure

NOVEMBER 29, 2023

Methods and results Patients ( n  = 5661) included in the PARADISE MI trial (Prospective ARNI vs. ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI) were stratified according to MRA. Primary outcomes in this substudy were worsening heart failure or cardiovascular death.

Myocardial Infarction 40

Myocardial Infarction ACE Inhibitor Heart Failure Pulmonary 40

Dr. Sanjay Gupta

MARCH 6, 2022

So she went back in 4 weeks and this time saw another doctor who asked her to stop the inhalers and suggested that it could be her heart and organised a chest X-ray and blood tests. Medications that improve quality of life in heart failure for example include diuretics.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40

EMS 12-Lead

MAY 8, 2022

1] In their publication, Sclarovsky and Birnbaum discovered that with each grading escalation there is less salvageable myocardium and higher likelihood of heart failure at hospital discharge (an inversely proportional relationship). ACE inhibitors, or potassium-sparing diuretics), are particularly susceptible.

ACE Inhibitor 52

ACE Inhibitor Ischemia STEMI Physiology 52

Open Heart

DECEMBER 2, 2024

Introduction Heart failure with reduced ejection fraction (HFrEF) guidelines recommend ‘four pillars’ of medical therapy and device therapy if left ventricular ejection fraction (LVEF) remains ≤35% after 3 months optimum medical therapy. There were no heart failure hospitalisations.

ACE Inhibitor 52

ACE Inhibitor Heart Failure Cardiomyopathy Outcomes 52